share_log

領航醫藥生物科技:延遲刊發截至二零二二年三月三十一日止年度之經審核年度業績及截至二零二二年三月三十一日止年度之未經審核年度業績公告

INNOVATIVE PHAR: DELAY IN PUBLICATION OF AUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2022 AND ANNOUNCEMENT OF UNAUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2022

Jun 29, 2022 18:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more